Abbott Laboratories
Davenport initiated Abbott Laboratories during the quarter, viewing it as a diversified healthcare franchise with a long record of dividend growth. The acquisition of Exact…
ABT
5 published ideas on Abbott Laboratories across 5 funds — 5 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Abbott Laboratories: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Davenport initiated Abbott Laboratories during the quarter, viewing it as a diversified healthcare franchise with a long record of dividend growth. The acquisition of Exact…
The fund initiated Abbott after the shares fell roughly 35% from their 2025 high and reached what it described as a 10-year-low valuation. Abbott provides diversified exposure…
The fund initiated Abbott after the stock fell roughly 35% from its 2025 high and reached what the team viewed as a 10-year-low valuation. Abbott's diversified businesses span…
Matrix initiated a new partial position in Abbott Laboratories after a significant share-price pullback. The fund likes Abbott's diversified healthcare businesses, recurring…
The Insiders Fund likes Abbott as a blue-chip healthcare company with an exceptionally long record of increasing dividends. Its device, diagnostics and nutrition businesses offer…